Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Phosphate Therapeutics logo — Advancing mineral-derived hospital pharmaceuticals for criti...

Phosphate Therapeutics

Advancing mineral-derived hospital pharmaceuticals for critical renal disease treatment through Phase 2 development.

Founded 2011 Venture round Total: $10.50M Biotechnology, Health Care +1

General Information

Company Name Phosphate Therapeutics
Founded Year 2011
Industries Biotechnology, Health Care, Health and Wellness
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with Phosphate Therapeutics. To contact Phosphate Therapeutics, visit phosphatetx.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Phosphate Therapeutics compare?

A PDF of Phosphate Therapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Phosphate Therapeutics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Phosphate Therapeutics

Phosphate Therapeutics, based in the UK, is an independent specialty pharmaceutical firm dedicated to developing hospital pharmaceuticals derived from minerals. The company plans to utilize the funding to finalize Phase 2 development of its phosphate binder (PT20) aimed at treating late-stage renal disease patients suffering from systemic phosphate buildup, hyperphosphataemia. The global rights for this treatment were acquired from the Medical Research Council. Founded in 2011, the company secured a significant €10.50MVenture Round investment on 05 March 2012 from Inventages. Phosphate Therapeutics is positioned at the intersection of Biotechnology, Health Care, and Health and Wellness industries, taking strides in advancing mineral-derived hospital pharmaceuticals for critical renal disease treatment through Phase 2 development.

Business keywords: Pharmaceuticals, Mineral-derived, Renal disease treatment, Phosphate binder, Hyperphosphataemia, Medical Research Council, Specialty pharmaceuticals, Phase 2 development, UK-based company

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round €10.50M 1
Inventages
Inventages
05 Mar 2012

Phosphate Therapeutics Alternatives & Competitors

View All Alternatives
Phosphate Therapeutics vs
Shield Therapeutics plc
Shield Therapeutics plc United Kingdom

Helping patients become people again

Post-IPO Debt
71 employees
Biotechnology, Health and Wellness
Phosphate Therapeutics vs
Cavion
Cavion

Empowering therapies for cancer and neurologic diseases through pioneering ion channel inhibition

Series A
Biotechnology, Health Care
Phosphate Therapeutics vs
Trimel Pharmaceuticals
Trimel Pharmaceuticals

Pioneering innovative solutions for male hypogonadism, female sexual dysfunction, and respiratory di...

Post-IPO Equity
Biotechnology, Health Care
View all alternatives

FAQ About Phosphate Therapeutics

Advancing mineral-derived hospital pharmaceuticals for critical renal disease treatment through Phase 2 development.
Phosphate Therapeutics was founded in 2011.
Phosphate Therapeutics operates in Biotechnology, Health Care and Health and Wellness. Its work centres on Pharmaceuticals, Mineral-derived, Renal disease treatment and Phosphate binder.
Phosphate Therapeutics has completed 1 funding round, raising a total of $10.50M. The latest funding stage is Venture round.
Top alternatives and competitors to Phosphate Therapeutics include Shield Therapeutics plc, Cavion, Trimel Pharmaceuticals, TransPharma Medical, Tribute Pharmaceuticals Canada. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Phosphate Therapeutics and Shield Therapeutics plc are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Phosphate Therapeutics, https://bouncewatch.com/company/phosphate-therapeutics, updated 26 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout